Effects of Acid-Reducing Agents on the Pharmacokinetics of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer
Crossref DOI link: https://doi.org/10.1007/s12325-022-02286-z
Published Online: 2022-08-13
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Bomin
Lee, Jungwook
Jang, Hyunwoo
Lee, Nami
Mehta, Jaydeep
Jang, Seong Bok http://orcid.org/0000-0002-3815-8554
Text and Data Mining valid from 2022-08-13
Version of Record valid from 2022-08-13
Article History
Received: 16 June 2022
Accepted: 27 July 2022
First Online: 13 August 2022